ACTRN12612000449831已完成4 期
Time to reach steady state insulin levels following a clinically-relevant increment and reduction in subcutaneous basal insulin infusion rates administered via an insulin pump in adults with type 1 diabetes
St Vincent's Hospital, Melbourne0 个研究点目标入组 12 人开始时间: 2012年4月20日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Clinical diagnosis of type 1 diabetes, managed with insulin pump therapy for minimum of 3 months, established insulin:carbohydrate ratio, established insulin sensitivity, established basal insulin delivery profile including a rate of 0.60-1.40 units per hour overnight (without significant variation during this period).
排除标准
- •Pregnancy or planned pregnancy, episode of diabetic ketoacidosis or major hypoglycaemia (requiring third party assistance) within the last 3 months, significant renal impairment (estimated glomerular filtration rate <40 mL per min), unresolved adverse skin condition in the area of cannula or device placement, body mass index >30 or <18, allergy to insulin aspart.
研究者
相似试验
招募中
不适用
Effectiveness of artificial pancreas in perioperative glycemic controlDiabetes mellitus, Hepatocellular carcinoma, Pancreatic cancerJPRN-UMIN000048616Okayama Saiseikai General Hospital50
尚未招募
3 期
Effect of Oral Insulin on Time to Reach Full Enteral Feeding in Preterm Infants less than 32 weeks of gestation and less than 1250 gram: A randomised controlled trialCTRI/2024/05/067912Dr Neelam Kler
已完成
不适用
Evaluation of long-acting insulin dose corresponding to lixisenatide dose in combination therapy of insulin and lixisenatideType 2 diabetes mellitusJPRN-UMIN000012024Kitano Hospital, The Tazuke Kofukai Medical Research Institute40
已完成
不适用
The measurement of insulin sensitivity index in normoglycemic healthy Korean subjectsKCT0003156Gachon University Gil Medical Center30
进行中（未招募）
1 期
Pilot Trial to preserve residual insulin secretion in children and adolescents with recent onset Type 1 diabetes by using GAD-antigen (Diamyd) therapy in combination with Vitamin D and Ibuprofen .Type 1 diabetes in children and adolescentsEUCTR2012-003251-11-SEinköping university